Intra-day variation of in vivo prostaglandin F2α formation in healthy subjects

Prostaglandins and Other Lipid Mediators

Volumn 80, Issue 1-2, 2006, Pages 93-99

  Helmersson, Johanna ^a   Basu, Samar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cyclooxygenase; Daily variation; Human; Prostaglandin F2

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; BIOLOGICAL RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MALE; NORMAL HUMAN; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS; URINE LEVEL; VASOCONSTRICTION;

ADULT; CIRCADIAN RHYTHM; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33745819631     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.05.007     Document Type: Article

References (26)

1. Samuelsson B., Hammarström S., and Borgeat P. In: Weissman G. (Ed). Advances in inflammation research (1979), Raven Press, New York 405
2. Basu S., Kindahl H., Harvey D., and Betteridge K.J. Metabolites of PGF2 alpha in blood plasma and urine as parameters of PGF2 alpha release in cattle. Acta Vet Scand 28 (1987) 409
3. Samuelsson B. Quantitative aspects on prostaglandin synthesis in man. Adv Biosci (1973) 7
4. Samuelsson B., Goldyne M., Granström E., et al. Prostaglandins and thromboxanes. Annu Rev Biochem 47 (1978) 997
5. Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostagland Leukot Essent Fatty Acids 58 (1998) 347
6. Basu S., and Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 438 (1998) 159
7. Basu S., and Eriksson M. Lipid peroxidation induced by an early inflammatory response in endotoxaemia. Acta Anaesthesiol Scand 44 (2000) 17
8. Mutschler D.K., Eriksson M.B., Wikström B.G., et al. Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 31 (2003) 1780
9. Basu S., Whiteman M., Mattey D.L., and Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 60 (2001) 627
10. Basu S., Larsson A., Vessby J., Vessby B., and Berne C. Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diab Care 28 (2005) 1371
11. Helmersson J., Vessby B., Larsson A., and Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109 (2004) 1729
12. Helmersson J., Larsson A., Vessby B., and Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F(2)-isoprostane formation in elderly men. Atherosclerosis 181 (2005) 201
13. Basu S., Steffen L.M., Vessby B., et al. Obesity in 15-year-old adolescents is related to oxidative stress and inflammation. Diabetologia 48 Suppl 1 (2005) A138 [abstract]
14. Helmersson J., and Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostagland Leukot Essent Fatty Acids 61 (1999) 203
15. Helmersson J., and Basu S. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans. Prostagland Leukot Essent Fatty Acids 65 (2001) 99
16. Goff A.K., Basu S., and Kindahl H. Measurement of 11-ketotetranor PGF metabolites: an approach for monitoring prostaglandin F2alpha release in the mare. Theriogenology 21 (1984) 887
17. Basu S., and Kindahl H. Development of a continuous blood collection technique and a detailed study of prostaglandin F2 alpha release during luteolysis and early pregnancy in heifers. J Vet Med A 34 (1987) 487
18. Chan P.H., Yurko M., and Fishman R.A. Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 38 (1982) 525
19. Rao G.N., Runge M.S., and Alexander R.W. Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta 1265 (1995) 67
20. Granström E. On the metabolism of prostaglandin F2 in female subjects. Structures of two metabolites in blood. Eur J Biochem 27 (1972) 462
21. Walker V. Clinical studies of plasma PGF2 alpha M, the circulating prostaglandin F2 alpha metabolite. Clin Chim Acta 124 (1982) 327
22. Helmersson J., Mattsson P., and Basu S. Prostaglandin F2alpha metabolite and F2-isoprostane excretion rates in migraine. Clin Sci (London) 102 (2002) 39
23. Schlegel W., Urdinola J., and Schneider H.P. Radioimmunoassay for 13,14-dihydro-15-ketoprostaglandin F2 alpha and its application in normo- and anovulatory women. Acta Endocrinol (Copenhagen) 100 (1982) 98
24. Hauksson A., Åkerlund M., Forsling M.L., and Kindahl H. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive. J Endocrinol 115 (1987) 355
25. Kurokawa K., Tanaka H., Tanaka S., and Abe S. Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. Chest 120 (2001) 1822
26. Wennmalm A., Benthin G., Granström E.F., Persson L., and Winell S. 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24 h excretion. Clin Sci (London) 83 (1992) 461